Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Biomedical Research topic

No spam. Unsubscribe anytime.

San Diego supervisors back region’s biomedical institutions, urge federal reinvestment after NIH action

3657015 · June 4, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The County Board of Supervisors voted unanimously to express concern about recent federal actions affecting NIH funding and to urge Congress and federal agencies to sustain research investments that support San Diego’s life‑science cluster.

San Diego County supervisors voted unanimously to adopt a resolution expressing concern about recent federal actions affecting the National Institutes of Health and to urge federal leaders to safeguard and reinvest in biomedical research funding that underpins the region’s life‑science economy.

The board’s action followed a presentation by Nikia Clark of the San Diego Regional Economic Development Corporation, who told supervisors the region receives more than $1 billion a year in NIH and NSF research funding and that proposals to cap indirect cost rates or otherwise reduce federal research support would have immediate and long‑term effects on jobs and the innovation pipeline.

“Research funding catalyzes early‑stage development and draws in close to $6 billion in venture capital annually,” Clark said during the presentation. She described an analysis estimating that a proposed cut in the NIH indirect cost reimbursement from roughly 50–60% down to 15% could reduce regional research funding by about $448 million and lead to a direct loss of roughly 1,300 jobs, with additional ripple effects.

Supervisor Jim Desmond, who brought the item forward, said he had received substantial constituent outreach from districts heavily concentrated with research institutions and life‑science employers. “San Diego is 1 of the leading biomedical research destinations in the world,” Desmond said, and he highlighted examples in which NIH‑funded work led to treatments that later reached patients.

Why this matters: San Diego’s biotechnology and research cluster is tightly linked to federal research dollars. County staff and the EDC emphasized that cuts or major changes to federal research policy could reduce university and institute capacity, curtail early‑stage research that fuels startups, and contribute to layoffs in the private sector.

What the board did: The board adopted a resolution “expressing concern regarding recent federal actions toward the National Institutes of Health that negatively impact our biomedical sector and calls for increased federal funding for the NIH, including funding state‑of‑the‑art scientific infrastructure at sustainable levels.” The motion was made by Supervisor Jim Desmond and approved unanimously.

What officials said next: Clark and supervisors acknowledged uncertainty about how federal policy might settle in the months ahead and emphasized coordinated advocacy. Clark noted that some philanthropic and regional emergency funds have been mobilized to soften immediate impacts but said those efforts cannot replace sustained federal research investment.

Context and next steps: Clark and supervisors urged continued outreach to congressional delegations and federal agencies and said the county would participate in regional advocacy and education efforts about the economic and clinical value of federal research funding. The resolution does not itself change county spending or create a new program; it is a formal statement urging federal reinvestment and signaling the county’s interest in the issue.

Ending note: County and university officials told the board they would continue monitoring developments in Washington and work with San Diego institutions on advocacy and mitigation strategies if federal research policies change.